Amari Martina, Brioschi Federica Alessandra, Auletta Luigi, Ravasio Giuliano
Department of Veterinary Medicine and Animal Sciences-DIVAS, Università degli Studi di Milano, 26900 Lodi, Italy.
Animals (Basel). 2025 Aug 10;15(16):2341. doi: 10.3390/ani15162341.
Radiofrequency ablation (RFA) and pulsed radiofrequency (PRF) are non-pharmacological techniques employed in humans for chronic pain, but their veterinary application is unexplored. This pilot study evaluated clinical effects of RFA and PRF in twenty-four horses with chronic distal forelimb lameness. Ultrasound-guided RFA (N = 8; 60-90 °C, 2-8 min) or PRF (N = 16; 42 °C; 12 min) was applied to palmar digital nerves. Lameness was scored (American Association of Equine Practitioners scale) at baseline and monthly for six months (T1-T6). At T2, partial- and non-responders in both groups received PRF. Complications and return to previous work were recorded. At T2, the PRF group had significantly lower lameness scores (1, 0-3) than the RFA group (3, 2-4; < 0.001) and significantly improved from baseline (3, 2-4; < 0.01). RFA caused more complications (N = 6) than PRF (N = 1; < 0.001), including increased lameness and allodynia. Sixteen horses (RFA: N = 7; PRF: N = 9) were retreated at T2. Overall, lameness significantly improved from T2 (2, 0-4) to T6 (0, 0-3; < 0.001). At T6, 83% (19/23) of horses resumed previous work. RFA was ineffective and caused complications, whereas PRF appeared safer and more effective. Two PRF treatments yielded better outcomes with fewer side effects and may help manage lameness and associated pain for up to six months.
射频消融(RFA)和脉冲射频(PRF)是用于治疗人类慢性疼痛的非药物技术,但它们在兽医领域的应用尚未得到探索。这项前瞻性研究评估了RFA和PRF对24匹患有慢性前肢远端跛行马的临床效果。在超声引导下,对掌侧指神经应用RFA(n = 8;60 - 90°C,2 - 8分钟)或PRF(n = 16;42°C;12分钟)。在基线时以及之后的6个月内每月(T1 - T6)对跛行进行评分(美国马术从业者协会评分标准)。在T2时,两组中的部分反应者和无反应者接受PRF治疗。记录并发症情况以及恢复先前工作的情况。在T2时,PRF组的跛行评分(1,0 - 3)显著低于RFA组(3,2 - 4;P < 0.001),并且与基线相比有显著改善(3,2 - 4;P < 0.01)。RFA引起的并发症(n = 6)比PRF(n = 1;P < 0.001)更多,包括跛行加重和异常性疼痛。16匹马(RFA:n = 7;PRF:n = 9)在T2时接受再次治疗。总体而言,跛行从T2(2,0 - 4)到T6(0,0 - 3;P < 0.001)有显著改善。在T6时,83%(19/23)的马恢复了先前的工作。RFA无效且会引起并发症,而PRF似乎更安全、更有效。两次PRF治疗产生了更好的效果,副作用更少,并且可能有助于在长达6个月的时间内控制跛行及相关疼痛。